CN202621154U - Medicament producing system - Google Patents
Medicament producing system Download PDFInfo
- Publication number
- CN202621154U CN202621154U CN 201220209829 CN201220209829U CN202621154U CN 202621154 U CN202621154 U CN 202621154U CN 201220209829 CN201220209829 CN 201220209829 CN 201220209829 U CN201220209829 U CN 201220209829U CN 202621154 U CN202621154 U CN 202621154U
- Authority
- CN
- China
- Prior art keywords
- agitated reactor
- valve
- pharmaceutical production
- raw material
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
The utility model discloses a medicament producing system, which comprises a reaction kettle and a raw material bucket connected with the reaction kettle, wherein the reaction kettle is connected with the raw material bucket through a medicament guiding device. The system has the advantages of simple and convenient principle, small quantity of used equipment, realization of large-scale, batch and automatic medicament production, increase in the yield and production efficiency of medicaments, and improvement on the competitive strength of an enterprise.
Description
Technical field
The utility model relates to a kind of system, especially relates to a kind of system that is used for pharmaceutical production.
Background technology
Medicine is the industry of high-tech, excessive risk, high investment, high repayment, is developed country's competition focal point always, and along with development of economic globalization, international competition is growing more intense.Pharmaceuticals industry is for protection and promote people ' s health, improve the quality of living, for family planning, disaster relief epidemic prevention, military supplies war preparedness and promote economic development and social progress all has a very important role.Trans-corporation through large-scale associating and merger and international capital market running, sets up global production and sales network in order to enhance our international competitiveness, and extends volume growth.Trans-corporation is increasing to the influence of World Economics, makes the rival of China's pharmaceuticals industry ever more powerful that becomes.The internationalization of the domestic market and intellectual property protection are strict more, make market competition become more direct and of vital importance.Worldwide economic restructuring makes developing countries such as India become the powerful rival of China.The develop rapidly of modern biotechnology will produce revolutionary influence to medical industry, to the in-depth of difficult diseases understanding, and the appearance of numerous new bio technical agents, rebuilding traditional industry etc. with biotechnology all greatly to change the looks of medical industry.World developed country utilizes the advantage on fund, technology, the market, implements monopolization, and China's medicine will launch the competition of a new round at biological technical field with developed country.
Along with being filled with of back to nature trend, the international market increases the demand of natural drug day by day.At present cosmopolitian plant goods sales volume is nearly 30,000,000,000 dollars, and wherein the natural drug sales volume has reached 16,000,000,000 dollars, and with the speed increase in year 10%.For this reason, various countries competitively adopt modern technologies research and development traditional medicine, seize international natural drug market.This explores world market for China's Chinese medicine opportunity is provided.China has possessed relatively richer medical industry material base, and the proportion that the medical industry gross output value accounts for GDP is 2.7%.Big type of bulk drug output such as vitamin C, penicillin Nacl, paracetamol ranks first in the world, and the preparation production capacity ranks first in the world.China's medicine export amount accounts for 2% of global medicine export amount, but the average annual growth rate of Chinese medicine outlet has reached more than 20%, and the international average level is 16%.Meanwhile, Chinese drug market status constantly promotes, the share that accounts for world's drug market by 1978 0.88% rise to 2008 8.25%.Pharmaceutical production need realize scale, raises the efficiency.
The utility model content
The purpose of the utility model is to overcome the shortcoming and defect of above-mentioned prior art; A kind of system that is used for pharmaceutical production is provided; This system has realized scale, mass and the automation of pharmaceutical production, has improved the output and the production efficiency of medicine, has improved Enterprises'Competitiveness.
The purpose of the utility model realizes through following technical proposals: a kind of system that is used for pharmaceutical production, and comprise agitated reactor and be connected with Raw material pail with agitated reactor, connect through leading medicine device between said agitated reactor and the Raw material pail.
Said leading is provided with the material loading valve between medicine device and the agitated reactor.
The said medicine device of leading is connected with flow-limiting valve, and said flow-limiting valve is connected with leads Teat pipette.
Said agitated reactor is provided with the exhaust-valve with its internal communication.
Said agitated reactor is provided with the dosing valve with its internal communication.
Be provided with return valve between said dosing valve and the agitated reactor.Return valve is used for the medicine of agitated reactor bottom is produced backflow.
In sum, the beneficial effect of the utility model is: this system principle is easy, and use equipment is few, has realized scale, mass and the automation of pharmaceutical production, has improved the output and the production efficiency of medicine, has improved Enterprises'Competitiveness.
Description of drawings
Fig. 1 is the structural representation of the utility model.
Mark and corresponding parts title in the accompanying drawing: 1-dosing valve; 2-return valve; 3-exhaust-valve; 4-material loading valve; 5-lead medicine device; 6-flow-limiting valve; 7-lead Teat pipette; 8-Raw material pail; 9-agitated reactor.
The specific embodiment
Below in conjunction with embodiment and accompanying drawing, the utility model is done further to specify, but the embodiment of the utility model is not limited only to this.
Embodiment:
As shown in Figure 1, a kind of system that is used for pharmaceutical production comprises agitated reactor 9 and is connected with Raw material pail 8 with agitated reactor 9, connects through leading medicine device 5 between said agitated reactor 9 and the Raw material pail 8.
Said leading between medicine device 5 and the agitated reactor 9 is provided with material loading valve 4.Carry out material loading in 4 pairs of agitated reactors 9 of material loading valve, control material loading process, convenient and accurate.
The said medicine device 5 of leading is connected with flow-limiting valve 6, and said flow-limiting valve 6 is connected with leads Teat pipette 7.Lead 7 pairs of Teat pipettes and lead medicine device 5 power is provided, make that to lead the medicine process more quick, flow-limiting valve 6 is set, prevent that raw material in the Raw material pail 8 from producing to reflux, damage and lead Teat pipette 7.
Said agitated reactor 9 is provided with the exhaust-valve 3 with its internal communication.Exhaust-valve 3 is used for discharging the unnecessary air of agitated reactor 9, guarantees the environment of pharmaceutical production, improves the quality of medicine.
Said agitated reactor 9 is provided with the dosing valve 1 with its internal communication.Dosing valve 1 is used for agitated reactor 9 is carried out dosing, makes that the production process of agitated reactor 9 is continuous.
Be provided with return valve 2 between said dosing valve 1 and the agitated reactor 9.Return valve 2 is used for the medicine of agitated reactor 9 bottoms is produced backflow, realizes the repeatedly utilization of raw material.
Take aforesaid way, just can realize the utility model preferably.
Claims (6)
1. a system that is used for pharmaceutical production comprises agitated reactor (9) and is connected with Raw material pail (8) with agitated reactor (9), it is characterized in that: connect through leading medicine device (5) between said agitated reactor (9) and the Raw material pail (8).
2. a kind of system that is used for pharmaceutical production according to claim 1 is characterized in that: said leading between medicine device (5) and the agitated reactor (9) is provided with material loading valve (4).
3. a kind of system that is used for pharmaceutical production according to claim 2 is characterized in that: the said medicine device (5) of leading is connected with flow-limiting valve (6), and said flow-limiting valve (6) is connected with leads Teat pipette (7).
4. a kind of system that is used for pharmaceutical production according to claim 1 is characterized in that: said agitated reactor (9) is provided with the exhaust-valve (3) with its internal communication.
5. a kind of system that is used for pharmaceutical production according to claim 1 is characterized in that: said agitated reactor (9) is provided with the dosing valve (1) with its internal communication.
6. a kind of system that is used for pharmaceutical production according to claim 5 is characterized in that: be provided with return valve (2) between said dosing valve (1) and the agitated reactor (9).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220209829 CN202621154U (en) | 2012-05-11 | 2012-05-11 | Medicament producing system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220209829 CN202621154U (en) | 2012-05-11 | 2012-05-11 | Medicament producing system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202621154U true CN202621154U (en) | 2012-12-26 |
Family
ID=47374399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201220209829 Expired - Fee Related CN202621154U (en) | 2012-05-11 | 2012-05-11 | Medicament producing system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202621154U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103386285A (en) * | 2012-05-11 | 2013-11-13 | 四川汇利实业有限公司 | System for medicine production |
-
2012
- 2012-05-11 CN CN 201220209829 patent/CN202621154U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103386285A (en) * | 2012-05-11 | 2013-11-13 | 四川汇利实业有限公司 | System for medicine production |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203575329U (en) | Water dispenser for chicken farm | |
| CN202621154U (en) | Medicament producing system | |
| CN203302107U (en) | Device for sweet potato soilless culture | |
| CN103386285A (en) | System for medicine production | |
| CN103183531A (en) | Ecological foliage spray agent for increasing peanut fruit and manufacturing method thereof | |
| CN202283364U (en) | Device for regulating height among sterilization frames | |
| CN202620751U (en) | System for distilling solvent | |
| CN202558194U (en) | Medicine belt conveyor with automatic counting function | |
| CN202288948U (en) | Sterilizing frame with height adjustment function | |
| CN207287231U (en) | A kind of accurate proportioner for the production of liquid pesticide preparation | |
| CN107080776A (en) | Improve traditional Chinese medicine oral liquid of livestock and poultry anti-stress ability and preparation method and application | |
| CN209865992U (en) | Chinese herbal medicine composition ration adds device for medicinal soap production | |
| CN101940613A (en) | Codonopsis pilosula and radix astragali oral solution as well as preparation method and application thereof on aspect of enhancing immunologic functions of livestock and poultry | |
| CN102229507A (en) | Cordyceps militaris water culturing medium | |
| CN202244574U (en) | Sterilizing stand for containing and conveying infusion bag | |
| CN103071173B (en) | Apparatus used for adjusting heights of sterilization racks | |
| CN104839689A (en) | Health product for invigorating spleen, nourishing stomach, resisting fatigue and enhancing immunity | |
| CN202314412U (en) | Honeyed pill making machine suitable for pharmaceutical industry | |
| CN202620752U (en) | Microwave distillation system | |
| CN103134112A (en) | Air-conditioning system convenient to control in pharmaceutical workshop | |
| CN103860562A (en) | Medicinal composition for establishing hyperuricemia animal model and application thereof | |
| CN218187933U (en) | Concentration device for producing magnesium nitrate | |
| CN201107100Y (en) | Large-capacity Chinese herbal medicine lever scale | |
| CN202561915U (en) | Air regulating system convenient to control in pharmacy workshop | |
| CN202568885U (en) | Pill making machine facilitating fixation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20130511 |